Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

27.22 +0.73 (+2.76%)
Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
39 40 Next >
News headline image
Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV in Older Adults
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Announces Positive Top-Line Results for Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Invites Public to View and Listen to Webcast of May 3 Conference Call with Analysts
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel COVID-19 Oral Treatment for Low- and Middle-Income Countries
From Pfizer Inc.
Via Business Wire
Vitiligo Market to Accelerate Substantially During the Forecast Period – DelveInsight | Key Companies – Amgen, Pfizer, Arcutis, Incyte Corp, and Sun Pharma Global FZE, and Others
Continue reading "Vitiligo Market to Accelerate Substantially During the Forecast Period – DelveInsight | Key Companies – Amgen, Pfizer, Arcutis, Incyte Corp, and Sun Pharma Global FZE, and Others" 
Via Get News
Acurx Pharmaceuticals Ibezapolstat Targets Front-Line Opportunity After Pfizer Fails To Reach CDI Trial Primary Endpoint (NASDAQ: ACXP)
Via AB Newswire
NetworkNewsAudio – Flora Growth Corp. (NASDAQ: FLGC) Makes Mark in ‘Whirlwind’ of M&A Activity
Via Investor Brand Network
iShowcaseTV offers diverse original content in different genres
Via AB Newswire
News headline image
Renewable Energy Investment Market Size, Share, Trends, Industry Growth, and Forecast 2028 Top Key Players Spectrum, Roche, Pfizer, Novartis, Merck, Bayer, Healthcare Amgen
Renewable Energy Investment Market Size, Share, Growth, Industry Trends, Business Scope, Global Providers, COVID-19 Impact and Forecast 2028 
Via SBWire
2022 Primed after 2021’s Record M&A Deals
Via Investor Brand Network
2022 Primed after 2021’s Record M&A Deals
Via Investor Brand Network
2022 Primed after 2021’s Record M&A Deals
NetworkNewsWire Editorial Coverage New York, NY – March 1, 2022 – Last year was a monumental year for merger and acquisition activity. Records worldwide weren’t just broken, they were smashed by M&A... 
Via FinancialNewsMedia
News headline image
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
News headline image
mRNA Vaccines in Medical Engineering Cancer Treatment
New York, NY -- (SBWIRE) -- 02/24/2022 -- The same mRNA technology used in Pfizer-BioNTech's and Moderna's Covid vaccines is being trialed as a unique new medical engineering cancer treatment. The way... 
Via SBWire
News headline image
Pfizer Invests $68.5 Million in New Pharma R&D Facility
New York, NY -- (SBWIRE) -- 02/24/2022 -- Gene therapy is a vital field and one generating a wealth of R&D jobs in pharma today. Companies such as Pfizer are keen to capitalize on progress, as this... 
Via SBWire
News headline image
Pfizer Invites Public to View and Listen to Webcast of Pfizer Keynote Presentation at Healthcare Conference
From Pfizer Inc.
Via Business Wire
U C, Inc., SMMR, Appoints New Board Member and CEO
U C, Inc., formerly named Symmetry Technologies, Inc. (OTC: SMMR), (the "Company"), announced today that, effective Feb. 14, 2022, it has appointed David Reckles as a new member to its Board of... 
Via Newswire.com
Topics Stocks
News headline image
Pfizer and OPKO’s Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency
From Pfizer Inc.
Via Business Wire
News headline image
European Medicines Agency Approves Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease and Pneumonia in Adults
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and BioNTech Provide Update on Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Reports Fourth-Quarter and Full-Year 2021 Results
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request From U.S. FDA
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Announces New Chief Development Officer
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and AWS Working Together to Speed Up Clinical Operations Trials
New York, NY -- (SBWIRE) -- 01/28/2022 -- Technology is vital to optimizing the process of clinical operations trials in the near future - and this has been brought one step closer by the news that... 
Via SBWire
News headline image
European Commission Approves LORVIQUA® (lorlatinib) as a First-Line Treatment for ALK-Positive Advanced Lung Cancer
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatment
From Pfizer Inc.
Via Business Wire
R&D Spending Increases Exponentially for Higher Standard of Breast Cancer Drug Treatments
Palm Beach, FL – January 27, 2022 – FinancialNewsMedia.com News Commentary – According to International Agency for Research on Cancer (IARC) published by the World Health Organization (WHO) in 2018,... 
Via FinancialNewsMedia
Topics Death Intellectual Property
News headline image
Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age
From Pfizer Inc.
Via Business Wire
Dietary Supplements Market Growing at a CAGR of 7.0% | Key Players are Amway, Herbalife Nutrition, ADM, Pfizer, Abbott Laboratories, Bayer, Glanbia, Nature’s Sunshine Products
Via AB Newswire
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.